Clinical and mutational spectrum of highly differentiated, paired box 3:forkhead box protein o1 fusion-negative rhabdomyosarcoma: A report from the Children's Oncology Group.
Lisa A TeotMichaela SchneiderAaron R ThornerJing TianYueh-Yun ChiMatthew DucarLing LinMarcin WlodarskiHolcombe E GrierChristopher D M FletcherPaul van HummelenStephen X SkapekDouglas S HawkinsAmy J WagersCarlos Rodriguez-GalindoSimone HettmerPublished in: Cancer (2018)
Interestingly, Hh and mTOR gene mutations were previously associated with rhabdomyomas, which are also known to preferentially arise at head/neck and genitourinary sites. Findings from this study further support the idea that PF-, highly differentiated RMS tumors and rhabdomyomas may represent a continuous spectrum of tumors. Cancer 2018;124:1973-81. © 2018 American Cancer Society.